Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|April 12, 2024
Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanomaPaweł Sobczuk, Michał Cholewiński, Piotr RutkowskiCancers|November 5, 2020
Dopamine D1 Receptor in CancerPaweł Sobczuk, Michał Łomiak, Agnieszka Cudnoch-JędrzejewskaHeart Failure Reviews|May 31, 2020
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system-from molecular mechanisms to therapeutic applicationsPaweł Sobczuk, Magdalena Czerwińska, Marcin Kleibert, et al.Oncology Letters|November 4, 2017
Renin angiotensin system deregulation as renal cancer risk factorPaweł Sobczuk, Cezary Szczylik, Camillo Porta, et al.Journal of Cancer Research and Clinical Oncology|October 10, 2023
Hedgehog pathway in sarcoma: from preclinical mechanism to clinical applicationNatalia Banaszek, Dominika Kurpiewska, Katarzyna Kozak, et al.Autoimmunity Reviews|January 26, 2026
LAG-3 in (auto)immunity and cancer - Emphasising its role in antigen presenting cellsAleksandra Wiśniewska, Elżbieta Sarnowska, Katarzyna Kozak, et al.Journal of Cancer Research and Clinical Oncology|November 23, 2023
Brain metastases of sarcoma: a rare phenomenon in rare tumoursWiktoria Jędrys, Aleksandra Leśniak, Aneta Borkowska, et al.Journal of Cancer Research and Clinical Oncology|July 1, 2022
In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcomaPaweł Sobczuk, Huber Bątruk, Paulina Wójcik, et al.Cancer Chemotherapy and Pharmacology|March 26, 2021
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney functionŁukasz Mielczarek, Anna Brodziak, Paweł Sobczuk, et al.Nature Reviews. Urology|October 12, 2019
Drug resistance in papillary RCC: from putative mechanisms to clinical practicalitiesAnna Brodziak, Paweł Sobczuk, Ewa Bartnik, et al.Pageof 3